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Variations Among Regions and Hospitals 
in Managing Chronic Illness: How Much 
Care Is Enough? 
 
Patterns of Variation: The Dartmouth Atlas Project 
Classic epidemiology looks at what happens to people who live 
in a defined region over time. For example, birth rate, the number 
of births that occur among populations over a year, is a common 
statistic that we’re all familiar with. Since the early 1990s we 
have conducted research at Dartmouth Medical School to convert 
that classic epidemiologic perspective into looking at what is 
happening in terms of the health care system itself. We ask how 
much care people are getting in different regions of the country. 
We want to know the patterns of that care. And we want to get 
into the causes of so-called unwarranted variation, that is, 
differences that cannot be explained on the basis of patient 
illness, the dictates of scientific medicine, or the preferences of 
patients. Those three key words—illness, preference, and 
science—ultimately don’t explain very much of the variation we 
see. 
We began the Dartmouth Atlas Project in 1993 as a study of 
health care markets in the United States, measuring variations in 
health care resources and their utilization among geographic 
areas. In recent years we have expanded our research agenda to 
include the resources and utilization among patients at specific 
hospitals. We use very large claims databases from the Medicare 
program and other sources to define where people go for medical 
care, what kind of care they receive, and whether increasing 
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investments in health care resources and their use result in better 
health outcomes. 
Data and Standards of Effective Practice 
The main source of our research data is Medicare, the 
government insurance program that covers virtually every 
American over age 65. The Medicare program maintains 
complete, accurate, and well documented records of 
hospitalizations, including each patient’s residence by ZIP code 
and the hospital the patient was admitted to. These files give us a 
reliable indication of the geographic patterns of health care use 
throughout the whole population of the United States, because 
research indicates that the patterns of where Medicare patients 
seek care is similar to patterns among younger patients 
(Wennberg and Gittelsohn 1980). 
At the beginning of the Dartmouth Atlas Project, we defined 
3,436 hospital service areas (HSAs), naturally occurring health 
care markets—geographic clusters of ZIP codes in which at least 
half of the hospital care received by Medicare patients is 
provided by a hospital or hospitals within the ZIP code cluster. 
Then we aggregated the HSAs, based this time on the geographic 
patterns of travel for tertiary care (specifically, major 
cardiovascular surgery and neurosurgery), into 306 hospital 
referral regions (HRRs). Most of the examples of patterns of care 
discussed in this policy brief are based on analysis of HRRs. For 
more information about data and methodology, see the Appendix. 
To define standards of effective care we employed the Health 
Plan Employer Data and Information Set (HEDIS), a set of 
standardized performance measures developed by the National 
Committee for Quality Assurance (NCQA) to track performance 
among managed care plans. HEDIS monitors more than 60 
different performance measures of effective care in the United 
States, covering a broad range of important health care issues (for 
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more information go to http://www.ncqa.org). Using these quality 
measures, we can determine which types of care are underused. 
We use distribution graphs to chart variations in how health care 
is delivered among the 306 HRRs. Each dot on the graph 
represents an HRR; the variable being studied is displayed on the 
vertical axis. 
We use the term rate to mean the number of events or amount of 
resources divided by the number in the population. For example, 
if an area with 100,000 enrollees has 810 hip fracture repairs, 
then the rate of hip fracture repair is 8.1 per 1,000 Medicare 
enrollees. The ratio of rates to the U.S. average is an HRR’s rate 
divided by the national rate. Ratios can be interpreted as a 
percent. For example, if an area’s ratio is 1.56, then that area’s 
rate is 56 percent higher than the national average; if an area’s 
ratio is .64, then that area’s rate is 36 percent below the national 
average. For details, go to the Dartmouth Atlas of Health website 
at http://www.dartmouthatlas.org/faq.php. 
1. Variation Based on Medical Need: Hip Fracture 
When looking at patterns of practice across the United States, 
sometimes, but rarely, the variation actually reflects medical 
need. The classic example of that is the hospitalization rate for 
people with hip fractures.  
The incidence of hip fracture varies somewhat in the United 
States, for reasons that are not clear. While you might expect that 
more people in the Northeast break their hips, perhaps because of 
poor traction in winter ice and snow, the fact is that a higher 
proportion of people break their hips in the South Central and 
Southeastern states than in other states. As a result, the rate of 
hospitalization for hip fractures differs slightly across HRRs. 
However, virtually everyone who breaks a hip spends time in a 
hospital. This is one of the rare examples where illness 
essentially drives the hospitalization rate. 
Lourie Memorial Lecture Policy Brief 
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Why can we say that? On the basis of clinical logic: people who 
break their hips nearly always go to the doctor because they’re in 
a great deal of pain and they can no longer walk. They don’t stay 
home wondering whether they should go or not. When they get to 
the doctor, it’s pretty easy to diagnose a broken hip, and an X-ray 
will confirm the fracture. So there’s no uncertainty about the 
diagnosis. Finally there’s no uncertainty about whether or not you 
hospitalize the patient. Virtually everybody with a broken hip is 
hospitalized. Thus, treatment of a hip fracture becomes a baseline 
from which we can say, this is the pattern of practice that we 
should see if medical necessity is driving care. 
2. Variations Resulting from Underuse of Effective Care 
Sometimes variation reflects the underuse of effective care, care 
that should be given. In the United States we are systematically 
underusing effective care. 
Effective Care: Beta-Blocker After Heart Attack 
Effective care refers to services of proven effectiveness. For 
example, administering beta-blocker treatment to patients who 
have had heart attacks really saves lives, based on evidence from 
clinical trials (Gottlieb, McCarter, and Vogel 1998). Furthermore, 
taking a beta-blocker if you have a heart attack does not involve a 
lot of tradeoffs; you get better with no complications. So it can be 
spoken of as effective care, something that should be done. The 
normatively correct rate for beta-blockers after heart attack is 
everyone who has a heart attack, with certain clinically 
identifiable exceptions. But in its annual report, The State of 
Health Care 2005, NCQA states that the rates of beta-blocker 
treatment after a heart attack by commercial plans, Medicare, and 
Medicaid were 96.2 percent, 94.0 percent, and 84.8 percent, 
respectively, in 2004. Failure to provide effective care such as 
this is an error of omission.  
John E. Wennberg 
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The HEDIS standard for comprehensive care for diabetics 
includes an annual eye exam to detect diabetic retinopathy, which 
is a leading cause of blindness. Figure 1 shows a distribution 
graph of patients who were given diabetic eye exams in 2001 in 
each of the 306 HRRs. The graph summarizes three features of 
the data: (1) no region approaches 100 percent compliance with 
the standard; (2) there is substantial variation in rates between the 
highest and lowest regions; and (3) that variation is not caused by 
a few outliers but is pervasive and widespread across the country. 
This is typical of most effective care measures. We’ve never 
found anywhere that comes close to 100 percent compliance. 
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Overall, in regard to the pattern of variation around the country, 
we’re somewhere in the zone of underuse (McGlynn et al. 2003). 
We haven’t reached optimal use. Effective care is cheap; a beta-
blocker doesn’t cost very much, nor does an eye exam. The irony 
is that we don’t do the things that we ought to do, and we spend a 
lot of money that doesn’t go toward getting those things done. 
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Figure 1. Variations in Rate of Diabetic Eye Exams, United States, 2001 
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3. Variations Reflecting Patient or Provider Preference 
Preference-sensitive conditions involve tradeoffs among the 
available options. There’s more than one treatment, and the 
outcomes are different. Treatment choices should be based on an 
informed patient’s own values. 
a. Patient Preference: Breast Cancer 
The surgical options for treating a woman with an early-stage 
breast cancer are an example of treatment choices that ought to 
be preference-sensitive. Most women could either be treated with 
a lumpectomy, a simple excision of the tumor, or with a removal 
of the breast, a mastectomy. The main outcome, in terms of life 
expectancy, is approximately identical irrespective of which 
treatment one takes. However, the other outcomes are quite 
different. The woman who chooses a mastectomy faces the loss 
of her breast, and probably the further choice of reconstructive 
surgery or a prosthesis. Women who choose lumpectomy will 
almost certainly receive radiation therapy and might have 
chemotherapy. Moreover, there’s a statistical chance that the 
cancer will recur and require a second procedure, usually a 
mastectomy. The evidence is clear that survivorship is the same. 
Not surprisingly, it turns out that different women have different 
opinions about which treatment they would prefer. 
However, our research indicates that local medical opinion has a 
strong influence on the choice of treatment. The variation in rates 
that we see in the Medicare population goes from almost nobody 
getting a lumpectomy in some regions to upwards of 50 percent 
of women in other regions. This can be traced back to differences 
in recommendations from the local physicians as to what course 
of treatment should be taken. A good deal of our research, which 
I do not address in detail here, shows that informing patients 
about treatment options actually leads to decisions more in line 
with the patients’ individual preferences. 
John E. Wennberg 
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b. Patient Preference and the Limits of Scientific Evidence: Prostate 
Cancer 
On the other hand, there’s a lot of clinical uncertainty about the 
actual outcomes of the treatment options for prostate cancer, 
including watchful waiting, radiation, and radical prostatectomy. 
The patient has to deal not only with the fact that outcomes of 
surgery are different from those of radiation or medical 
management, but also with the evidence that it is not clear 
whether he will live longer with one treatment or another. This 
demonstrates a second category of issues, the need to make 
patients understand the limits of scientific evidence when they’re 
making these decisions. 
c. Provider Preference: Orthopedic Surgery 
Choosing among valid surgical options obviously should be 
based on the patient’s own preferences, but provider opinion 
often determines which treatment is used. Here are a couple of 
examples. 
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Figure 2 illustrates the hospitalization rate for four different 
orthopedic procedures; each dot represents an HRR. From left to 
right are the hospitalization rates of hip fracture, knee 
replacement, hip replacement, and back surgery. The chances of 
having back surgery vary much more than the chances of being 
hospitalized for hip fracture. Most of the variation among the 
different procedures is associated with the information exchange 
relationship between the doctor and the patient regarding which 
treatment options to use. One example is back pain, and the 
decision whether to treat it with surgery or with medical 
management. 
Sometimes there are also huge differences in the likelihood of 
having common surgical procedures between regions that are 
geographically quite close. In 2004, we reported on variations in 
the rates of knee replacement, hip replacement, and back surgery 
operations in four Florida HRRs (Weinstein et al. 2004). As 
Figure 3 illustrates, in the Fort Myers HRR, the rate of knee 
replacements was about 48 percent higher than the national 
average; in Tampa, which is only a few miles away, the rate was 
5 percent lower than the national average. The most likely 
etiological factor here was the differences in the medical opinions 
of the physicians in those regions.  
You might surmise that these rates would correlate with the 
supply of orthopedic surgeons—but in fact there is no such 
correlation. And the reason that I believe that’s occurring is that 
orthopedic surgeons can do lots of different things: knee 
replacements, back surgery, carpal tunnel repairs, sports 
medicine, and so on. Surgeons, even once they’re specialized in a 
particular body area or system, become further specialized in 
certain procedures. So people find doctors or surgeons who 
concentrate on doing hips, or back surgery, or something else. 
And differences in individual opinions are sufficiently strong to 
override any correlation between surgeons and rates of surgical 
activity. This shows at least some indirect evidence, I think, of 
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the power of the decision process in directing clinical inputs and 
clinical outcomes. 
We don’t know what the true demand for these operations would 
be if informed patient choice was playing a role in decision 
making. We really don’t know what the optimal rate of any of 
these procedures is. This is an unfortunate complication, because 
the assumption is that there is some rational basis for the rate. We 
do know that when decision aids are carefully constructed for 
patients and patients are fully informed, the decisions are 
different than when that’s not happening. Interestingly, patients 
who are fully informed tend to choose surgery less often. At the 
same time, their decisions become better aligned with their 
values. In other words, in the case of breast cancer, someone who 
is really concerned about the risk of recurrence is more likely to 
choose mastectomy after an informed decision choice process, 
whereas someone who is really concerned about loss of her breast 
is more likely to choose lumpectomy. 
Figure 3. Surgical Signatures for Three Florida HRRs
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4. Supply-Sensitive Care: Variations Based on Capacity 
In 1961, Milton Roemer found that, in the presence of 
widespread health insurance, the per capita supply of hospital 
beds in a community is a major influence on the hospital 
utilization rate; more beds means more admissions and longer 
hospital stays. This has become known as Roemer’s law, and it 
illustrates supply-sensitive care with respect to the frequency of 
treatment of patients with chronic illness, including 
hospitalizations for medical conditions, stays in intensive care, 
visits to physicians, referrals to specialists, and imaging and other 
tests. 
For example, I talked earlier about the low variation in rates of 
hospital admissions for hip fractures. What happens when we 
relate the regional bed supply, that is, acute care beds per capita, 
to the hospitalization rate for hip fractures and a medical 
condition such as congestive heart failure? Rates of 
hospitalization for hip fracture basically don’t have any 
relationship with capacity: the incidence of the condition, not the 
capacity of the system, drives the utilization rate. 
This is not so for medical conditions. For chronically ill patients, 
more hospital beds means more hospitalization. 
Hospitalization for Chronic Illness 
Figure 4 shows the distribution of the average number of days in 
hospitals per decedent during the last six months of life. In some 
regions this average is about three weeks, but in other HRRs the 
average is six days—a three- or four-fold difference. 
Why do we focus so much on end-of-life care? Because all of 
these people have exactly the same prognosis: they were all dead 
at the end of the study period. Therefore, it’s very unlikely that 
illness differences explain the variations in intensity of care. 
Otherwise you’d have to conclude that people are deader in 
John E. Wennberg 
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Manhattan than anywhere else in the country, which seems 
highly unlikely. 
 Figur
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Variations of Care Within and Between Communities: The Last 
Six Months of Life 
The useful thing about Medicare data is that we can find 
everyone who died while enrolled in Medicare, and by going 
backward in time determine when and where they were 
hospitalized in the last two years of their lives. Almost everybody 
who has a serious chronic illness is hospitalized at least once. We 
assigned these people to the hospital they used most frequently. It 
turns out that when we assign them to the hospital they most 
frequently use, about 85 to 90 percent of all the inpatient activity 
for that patient occurs at that hospital. This then becomes a 
measure of the relative use rate of that individual. 
In 2004, we looked, in a sort of tongue-in-cheek way, at the US 
News & World Report’s 2001 list of the 77 “best” hospitals for 
geriatric disease and chronic lung disease (Wennberg et al. 2004). 
We found that the average number of days patients stayed in 
e 4. Patient Days in Hospital during the Last Six Months of Life, Medicare Decedents, 2001 
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hospitals during the last six months of life ranged from around 9 
days in some of the more conservative hospitals to almost a 
month (27 days) at the NYU Medical Center. Mount Sinai’s 
patients had an average of 22.8 days, and New York 
Presbyterian’s patients averaged 21.6 days. On the West Coast, 
UCLA’s patients averaged about 16 days, while patients of UCSF 
and Stanford averaged about 10 days. It is interesting to note that 
UCSF and UCLA are in the same system, and run by the same 
board of regents, yet they are quite different in the way they 
practice medicine. 
 
1.0
2.0
3.0
4.0
5.0
6.0
7.0
8.0
9.0
10.0
NY Presbyterian Hospital 4.5
Stanford University Hospital 4.3
UCLA Medical Center 9.2
Cedars-Sinai Medical Center 7.0
NYU Medical Center 6.7
Mount Sinai Hospital 2.8
UCSF Medical Center 2.6
 
Figure 5 shows how long people spend in intensive care units 
(ICU) on average. It turns out that UCLA is extremely aggressive 
in treating chronically ill people, particularly toward the end of 
life—the average number of days in ICU is 9.2 per decedent. In 
comparison, the UCSF Medical Center kept patients in the ICU 
only 2.6 days. But if you talked to the physicians at those 
facilities they wouldn’t have any idea that these variations are 
happening, until they see our data. 
Our data about access to care, measured as people who had one 
or more opportunities to visit a doctor, shows very little variation. 
Figure 5. Days Spent in Intensive Care Unit during Last Six Months of Life among 
Patients Receiving Most of Their Care in One of 77 “best” US Hospitals, 2001 
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US News & World Report’s 77 “best” hospitals, 2001 
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Almost everybody is getting into the system in Medicare. But the 
rate of visits to primary physicians and medical specialists varies 
by a factor of about five. So access is more or less uniform, but 
once in the system physicians treat patients very differently, 
depending on where they live. 
Another example of how the hospital capacity influences clinical 
choice is total physician visits during the last six months of life. 
It’s not surprising that visit rates—the overall number of visits, is 
highly related to the number of days in hospital. Once a patient is 
admitted to the hospital, the opportunity for physicians to visit is 
much greater. In some regions it is almost 60 visits; in Manhattan 
it’s quite high. But if we focus in on the 77 academic medical 
centers, there are 76 visits per person in the last six months of life 
at NYU, 54 at Mount Sinai, 22 at UCSF, and 27 at Stanford. The 
Los Angeles hospitals are quite high. Again, we see huge 
variability. From a policy perspective it is important to 
understand the double influence of the supply of physicians and 
the capacity of the hospital. You get a quadratic effect; basically 
you get a real crescendo of this effect as you have more beds and 
more hospitals. 
Variations in Per Capita Spending 
We’ve seen good evidence that the capacity of the system, both 
the numbers of doctors and the numbers of hospital beds, directly 
influence the relative frequency with which both visits and 
hospitalizations occur. When we look across the United States, 
we see huge differences in the per capita spending in Medicare. 
What kinds of clinical events explain it? It’s important to know 
because we need to understand the relative importance, in terms 
of the Medicare program’s dilemma right now, of the variations 
that we’ve been looking at.  
Figure 6 shows the relative reimbursement rates of the 306 
hospital referral regions, divided into four groups by level of 
spending. The black dots are regions being reimbursed more than 
Lourie Memorial Lecture Policy Brief 
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15 percent above the national average. The highest-
reimbursement quartile in 2000-2001 were reimbursed almost 
$10,000 per decedent, the lowest quartile (the white dots) 
reimbursed around $4,000. 
 
 
 
 
 
 
Figure 6. Medicare Per Capita Reimbursement, 2000-2001 
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When you increase spending, what do you get? Figure 7 shows 
that you get more supply-sensitive care: hospitalizations, visits to 
doctors—particularly specialists—and visits to a greater number 
of different doctors. The gray bar, designated as spending more 
than 15 percent below average, is the baseline. Days in hospital 
are 69 percent more frequent in the high-reimbursement regions. 
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Medical specialists’ visits are 2.5 times higher, and the 
percentage seeing 10 or more physicians is about 2.5 times 
higher. But what you don’t get, basically, is more effective care 
(Baicker and Chandra 2004). 
Effective care (see Figure 8) is essentially the same across all 
these regions, maybe even a little worse in the higher-spending 
ones. The right-hand columns show that the higher Medicare 
reimbursements don’t buy more discretionary surgery. Effective 
care is essentially independent of overall spending. 
 
 
 
 
 
 
Figure 9 illustrates the huge differences in the combined costs of 
Medicare inpatient and physician payments in managing 
chronically ill patients over the last six months of life in 77 
selected academic medical centers. Some of the hospitals in the 
sample were being reimbursed upwards of $39,000 per person in 
the last six months of life, while the lower-reimbursed regions 
were getting around $12,000 to $13,000. 
These spending patterns are not just a phenomenon in the last six 
months of life. In Figure 10, the vertical axis shows the amount 
spent per person in each of those hospitals in the last six months 
More than 15% Below Average
0-15% Below Average
0-15% Above Average
More than 15% Above Average
1.
00
1.
00
1.
001
.1
8
0.
98 1.
04
1.
38
0.
97 1.
03
1.
66
1.
00
0.
99
0.0
0.4
0.8
1.2
1.6
2.0
Medicare Reimbursements Effective Care Preference-Sensitive Care
(Discretionary Surgery)
1.
00
1.
00
1.
001
.1
8
0.
98 1.
04
1.
38
0.
97 1.
03
1.
66
1.
00
0.
99
Figure 8. Rates of Medicare Reimbursements, Effective Care, and Preference-Sensitive Care, 
 in Quartiles by Level of Spending, as a Ratio to Lowest-Spending Region, 2000-2001  
Ra
tio
 to
 Lo
we
st 
 
Sp
en
din
g R
eg
ion
 
Lourie Memorial Lecture Policy Brief 
16 
of life (Wennberg et al. 2004). The horizontal axis shows the 
amount spent in the 19th to 24th months prior to death. From the 
labels along that axis you can see that spending is much lower in 
the last 19 to 24 months—it ranges from about $2,000 to $7,000 
per person—but notice how highly correlated it is. In other 
words, this effect that we’re seeing is not just at the end of life of 
chronically ill patients; it’s across previous periods of life in the 
cohort. It’s an attribute of the system, not the disease or the 
individual patient’s need. 
Figure 10. Association between Total Medicare 
Payments 19-24 Months and 0-6 Months before  Figur
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This is important for policy reasons because it says that we can 
use end-of-life measures of differences in spending as estimates 
of what the actual costs are, independent of illness. I think that 
has a lot of policy implications. 
Is More Better? 
If we increase the frequency of use of supply-sensitive care in 
managing chronic illness—for physician visits, hospitalizations, 
intensive care—are we getting more, or not?  
There’s virtually no evidence from clinical trials about what the 
appropriate frequency of use of these services should be. 
Evidence-based medicine has nothing to do with this whole level 
of variability. You cannot go to, for example, the Clinical 
Evidence Concise, published by the British Medical Journal, and 
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find even a suggestion about when to hospitalize somebody with 
congestive heart failure. There are no rules or guidelines. So 
we’re stuck with having to resort to epidemiological evidence. 
One of the research agendas at Dartmouth has been to ask, “If 
you live in a high-spending region, like Miami, do you get better 
outcomes than if you live in one of the lower-spending regions?” 
To answer that question, Edward Fisher and colleagues (2003) 
looked at people in the United States who were hospitalized 
between 1993 and 1995 for three conditions—(1) hip fractures, 
(2) colon cancer with a surgical procedure, and (3) heart 
attacks—for which there is a literature of chart reviews. They 
followed those people over a period of time, up to five years, and 
looked at the survivorship of those patients depending on whether 
they live in a high- or a low-reimbursement region. Dividing the 
HRRs into five groups by spending level and comparing the 
highest reimbursement quintile to the quintile being reimbursed 
the least, we see that there was 61 percent more Medicare 
spending on people who live in Miami, Los Angeles, and 
Manhattan, compared to people who live in Rochester, 
Minnesota, and some other parts of the country. There were more 
doctors overall, particularly more internists and medical 
specialists, a few more surgeons, and fewer family practitioners. 
These high-cost regions are characterized as not being served by 
family practitioners. 
But if you look at the actual survival, you see that patients with 
hip fractures and colon cancer and heart attacks actually had 
higher mortality rates if they lived in the higher-spending regions 
than if they lived in the lower-spending regions. There was no 
difference in patients’ functional status and satisfaction with their 
care, and their perceptions were that their access to care was 
worse. 
How do we interpret the intensity of care when we don’t see any 
marginal advantage? Is it really good to see 10 or more doctors 
when you have a chronic illness? Regions where patients see lots 
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of doctors actually do relatively poorly on the effective care 
quality measures like beta-blockers and diabetic eye exams. The 
simple interpretation, the most direct hypothesis, is that if you 
have a lot of people involved in the patient’s care, no one is in 
charge and no one guides overall care. The consequences of 
failing to give some of these things like beta-blockers could be 
behind the variation that we’re seeing in terms of mortality. 
Medical error is common in hospitals, and if you hospitalize 
people twice as often, you’re going to have twice as many 
medical errors.  
We may have actually over-invested in care management of 
chronic illness. Our data seem to support the conclusion that, for 
longitudinal performance over fixed periods of time, and with 
relatively satisfactory performance on available quality measures, 
low-reimbursement, low-resource input, low-utilization regions 
or hospitals should be viewed as normatively better than regions 
that are on the higher side of the equation. 
Newly Released Hospital-Specific Data 
The Dartmouth Project has begun to make available hospital-
specific data for all U.S. hospitals, starting with California, on 
our web site, http://www.dartmouthatlas.org. This data enables 
direct comparisons of the efficiency of individual hospitals in 
treating patients with chronic illness based on the Medicare 
claims from hospitals and their associated physicians. The results 
make it possible to compare and rate market areas as well as 
individual hospitals on the efficiency with which they use health 
care resources. 
In November 2005, my colleagues and I published an article, 
based on our hospital-specific data for California, in which we 
compared per capita spending in the last two years of life in Los 
Angeles and Sacramento. In Los Angeles, Medicare spent 67 
percent more money than Sacramento—74 percent more for 
physician payments, and 67 percent for inpatients. Decedents in 
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Los Angeles used 61 percent more hospital beds, 2.3 times more 
ICU beds, and 89 percent more physician labor input. And what 
was the outcome? They have worse quality care in Los Angeles 
than in Sacramento. 
On all these relative efficiency criteria, Sacramento is a 
reasonable benchmark for asking questions about what’s going 
on in Los Angeles. Similar benchmarks are available in regions 
throughout the country: Rochester, New York, provides a 
benchmark for Syracuse, for example. 
Policy Issues 
As a result of this recent work, hospital-specific performance 
measures are now available for comparing patterns of practice in 
managing chronic illness. As we wrote in 2002, in reference to 
Medicare: 
We have identified three categories of unwarranted 
variation affecting the quality and efficiency of care 
supported by the Medicare program. To address these 
shortcomings, we propose the following goals for 
Medicare reform: (1) eliminate under-provision of 
effective care; (2) establish patient safety; (3) reduce 
scientific uncertainty through outcomes research; (4) 
establish shared decision making for preference-based 
treatments, chronic disease management, and end-of-life 
care; (5) establish accountability for capacity; and (6) 
promote conservative practice when greater care is 
wasteful if not harmful. (Wennberg, Fisher, and Skinner 
2002, W105) 
The first policy challenge will be to debate and find out whether 
you can get any consensus on this interpretation, because it’s 
quite radical.  
The next challenge would be to set the dynamics in place to 
reallocate excess capacity in a system that is suffused with 
(a) fee-for-service and (b) supply-induced demand. It’s a real 
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problem. My hope lies in the Section 646 (of the Medicare 
Modernization Act, MMA) demonstration projects, which enable 
providers to come forward with suggestions on how to reform 
Medicare reimbursement systems to accommodate the change. 
Otherwise, it could be chaotic. 
If we take this data serious, there’s a lot of hard work ahead. The 
general rule in my experience has been about 10 years of denial 
of data, five years of blaming somebody else for the problem, and 
finally a crisis in which they say “Maybe we should roll up our 
sleeves and get to work.” We don’t have that kind of time in 
terms of the train wreck that Medicare is heading toward—that 
our whole system is heading toward. 
Chronic disease is one of the major problems affecting all of us 
as we age, and we need to come to terms with the fact that our 
system is running in the wrong direction. We need to bring in 
some rational process improvement for learning what the 
preferred pathways are for managing chronic illness. And it will 
take all of us to do that kind of work. 
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Appendix 
The Medicare program maintains exhaustive records of 
hospitalizations, which makes it possible to define the patterns of 
use of hospital care. When Medicare enrollees are admitted to 
hospitals, the program’s records identify both the patients’ place 
of residence (by ZIP code) and the hospitals where the 
admissions took place (by unique numerical identifiers). These 
files provide a reliable basis for determining the geographic 
pattern of health care use, because research shows that the 
migration patterns of patients in the Medicare program are 
similar to those for younger patients (http://www.dartmouthatlas. 
org/faq/geogappdx.pdf). 
HSAs = hospital service areas are local health care markets for 
hospital care. An HSA is a collection of ZIP codes whose 
residents receive most of their hospitalizations from the hospitals 
in that area. HSAs were defined by assigning ZIP codes to the 
hospital area where the great proportion of their Medicare 
residents were hospitalized. Minor adjustments were made to 
ensure geographic continuity. This process resulted in 3,436 
HSAs. 
HRRs = hospital referral regions represent regional health care 
markets for tertiary medical care. Each HRR contains at least one 
hospital that performs major cardiovascular procedures and 
neurosurgery. HRRs were defined by assigning HSAs to the 
region where the greatest proportion of major cardiovascular 
procedures were performed. The process resulted in 306 hospital 
referral regions. For details on HSAs and HRRs, go to 
http://www.dartmouthatlas.org/faq/geogappdx.pdf. 
The Geographic Query Finder at http://www.dartmouthatlas.org/ 
data/finder.shtm enables consumers to locate ZIP codes by HSA 
and HRR, HSAs by HRR and state, and HRRs by state, based on 
year 2004 ZIP codes. 
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Rate = the number of events or amount of resources divided by 
the number in the population. For example, if an area with 
100,000 Medicare enrollees has 810 hip fracture repairs, then the 
rate of hip fracture repair is 8.1 per 1,000 enrollees. For rare 
events, the rate is often re-scaled to events per 100,000 persons. 
For details, go to http://www.dartmouthatlas.org/faq/appdx.pdf. 
References 
Baicker, Katherine, and Amitabh Chandra. 2004. “Medicare 
Spending, the Physician Workforce, and Beneficiaries' 
Quality of Care.” Health Affairs Web Exclusive (April 7): 
W4-184–W4-197. 
Fisher, Elliott S., David E. Wennberg, Thérèse A. Stukel, Daniel 
J. Gottlieb, F. L. Lucas, and Étoile Pinder. 2003. “The 
Implications of Regional Variations in Medicare 
Spending. Part 2: Health Outcomes and Satisfaction with 
Care.” Annals of Internal Medicine 138 (4) (February 18): 
288-298. http://www.annals.org/cgi/reprint/138/ 
4/288.pdf. 
Gottlieb, Stephen S., Roger J. McCarter, and Robert A. Vogel. 
1998. “Effect of Beta-Blockade on Mortality among 
High-Risk and Low-Risk Patients after Myocardial 
Infarction.” New England Journal of Medicine 339 (8) 
(August 20): 489-497. 
McGlynn, Elizabeth A., Steven M. Asch, John Adams, Joan 
Keesey, Jennifer Hicks, Alison DeCristofaro, and Eve A. 
Kerr. 2003. “The Quality of Health Care Delivered to 
Adults in the United States.” New England Journal of 
Medicine 348 (26) (June 26): 2635-2645. 
National Committee for Quality Assurance. 2005. The State of 
Health Care Quality 2005: Industry Trends and Analysis. 
Washington, DC: NCQA. http://www.ncqa.org/Docs/ 
SOHCQ_2005.pdf. 
John E. Wennberg 
23 
Roemer, Milton I. 1961. “Bed Supply and Hospital Utilization: A 
Natural Experiment.” Hospitals 35: 36-42. 
Weinstein, James N., Kristen K. Bronner, Tamara Shawver 
Morgan, and John E. Wennberg. 2004. “Trends and 
Geographic Variations in Major Surgery for Degenerative 
Diseases of the Hip, Knee, and Spine.” Health Affairs 
Web Exclusive (October 7): VAR-81-VAR-89. 
Wennberg, John E., Elliott S. Fisher, Laurence Baker, Sandra M. 
Sharp, and Kristen K. Bronner. 2005. “Evaluating the 
Efficiency of California Providers in Caring for Patients 
with Chronic Illnesses.” Health Affairs Web Exclusive 
(November 16): W5-526-W5-557. 
Wennberg, John E., Elliott S. Fisher, Thérèse A. Stukel, and 
Sandra M. Sharp. 2004. “Use of Medicare Claims Data to 
Monitor Provider-Specific Performance among Patients 
with Severe Chronic Illness.” Health Affairs Web 
Exclusive (October 7): VAR-5-VAR-18. 
Wennberg, John E., Elliott S. Fisher, and Jonathan S. Skinner. 
2002. “Geography and the Debate over Medicare 
Reform.” Health Affairs Web Exclusive (February 13): 
W96-W114. 
Wennberg, John E., and Alan M. Gittelsohn. 1980. “A Small 
Area Approach to the Analysis of Health Systems 
Performance.” HRP-0102101, DHHS (HRA)80-14012. 
Washington, DC: U.S. Department of Health and Human 
Services. 
